EN2: A candidate antigen for the development of targeted therapies in ovarian cancer.

Shadi Bokaee, A. Michael, C. Riley, M. Denyer, H. S. Pandha, N. E. Annels

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'EN2: A candidate antigen for the development of targeted therapies in ovarian cancer.'. Together they form a unique fingerprint.

Medicine & Life Sciences